Patients, caregivers, and healthcare providers are invited to join Memorial Sloan Kettering and The Leukemia & Lymphoma Society for this free, virtual program on treatment-free remission for CML patients. MSK’s Dr. Michael Mauro will provide an overview of treatment-free remission, including what it means and when patients should consider it as a potential treatment goal. He will then be joined by CML survivor Erin Zammett Ruddy for a conversation on treatment-free remission from the patient perspective.